By integrating the aforementioned observations of FMc in autoimmunity and transplantation immunobiology, we reasoned that allogeneic FMc might
provide immune surveillance for breast cancer in parous women.
Not exact matches
Using the JEDI technology, Mount Sinai researchers uncovered evidence that
immune cells can find cells in the brain expressing their target antigen, even in non-infected states, which
provides evidence of an
immune surveillance pathway within the body's central nervous system.
Allogeneic cells, particularly mismatched or haploidentical cells, in the context of hematopoietic transplantation have been found to
provide potent
immune surveillance for both hematologic and solid tumor malignancies in a process referred to as graft - versus - tumor [13]--[15].